SEC asks for more data to grant full market approval to...
New Delhi [India], January 14 (ANI): The Drugs Controller General of India's (DCGI) Subject Expert Committee...
DCGI's SEC to review applications of Bharat Biotech, SII for...
New Delhi [India], January 14 (ANI): Drugs Controller General of India (DCGI)'s Subject Expert Committee will...
Bharat Biotech gets SEC approval for phase 3 clinical trials...
New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India...
SEC to hold meeting on Bharat Biotech's Nasal vaccine booster dose
SEC recommends emergency use authorization of Covovax,...
New Delhi [India], December 28 (ANI): After reviewing all applications and data, the Subject Expert Committee...
SEC to take decision on antiviral Covid pill today
New Delhi [India], December 27 (ANI): After reviewing all applications and data on antiviral pills, the Subject...
No recommendations for COVID-19 booster dose by SEC: Sources
New Delhi [India], December 11 (ANI): The Subject Expert Committee (SEC) under Central Drugs Standard Control...
Subject Expert Committee to meet tomorrow to discuss approval...
COVID-19 vaccination for children: CDSCO approved ZyCoV-D for...
Covaxin for 2-18 yrs: Centre examining Expert Committee...
New Delhi [India], November 30 (ANI): The Central government is examining the recommendation of the Subject...
Administration of ZyCoV-D vaccine requires special training;...
New Delhi [India], October 21 (ANI): Zydus Cadila's vaccine - ZyCoV-D is the first indigenously manufactured...
Awaiting regulatory approval for rolling out Covaxin for...
New Delhi [India], October 12 (ANI): The Subject Expert Committee (SEC) has given a recommendation to the Drugs...
Copyright © aninews.in | All Rights Reserved.